3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
21
Myelodysplastic Syndromes
14
Precursor Cell Lymphoblastic Leukemia-Lymphoma
11
Leukemia
7
Myeloproliferative Disorders
6
Lymphoma, Non-Hodgkin
6
Anemia, Refractory, with Excess of Blasts
6
Lymphoma
5
Leukemia, Myelomonocytic, Chronic
5
Hodgkin Disease
5
Multiple Myeloma
4
Graft vs Host Disease
4
Leukemia, Myelomonocytic, Juvenile
3
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
3
Leukemia, Lymphocytic, Chronic, B-Cell
3
Leukemia, Biphenotypic, Acute
3
Hematologic Neoplasms
3
Congenital Abnormalities
3
Waldenstrom Macroglobulinemia
2
Thrombocythemia, Essential
2
Sezary Syndrome
2
Recurrence
2
Primary Myelofibrosis
2
Precancerous Conditions
2
Polycythemia Vera
2
Pdgfra-Associated Chronic Eosinophilic Leukemia
2
Myelodysplastic-Myeloproliferative Diseases
2
Mycosis Fungoides
2
Lymphoma, T-Cell, Cutaneous
2
Lymphoma, Follicular
2
Interventions
repotrectinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Neuroectodermal Tumors
×
Busulfan
×
90 days
×
Clear all
No trials found.